1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1a activity for the treatment of cognitive impairment | Patent Number 08969355

US 08969355 B2
Application Number14480949
Publication NumberUS 20140377363 A1
Pendency5 months, 25 days
Filled DateSep 9, 2014
Priority DateJun 16, 2006
Publication DateDec 25, 2014
Expiration DateJun 15, 2026
Inventor/ApplicantsRene Holm
Andre Faldt
Heidi Lopez de Diego
Tine Bryan Stensbol
Nicholas Moore
Benny Bang-Andersen
Arne Mork
ExaminesPOLANSKY, GREGG
Art Unit1621
Technology Center1600
Assignments
H. Lundbeck As
Current
H. Lundbeck As
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.